{
  "main_header": {
    "sid": 605306,
    "name": "Concord Drugs",
    "stock_name": "Concord Drugs",
    "full_name": "Concord Drugs Ltd",
    "name_url": "stocks-analysis/concord-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.87",
    "chg": 0.87,
    "chgp": "2.81%",
    "dir": 1,
    "prev_price": "31.00",
    "mcapval": "33.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538965,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE858L01010",
    "curr_date": "Apr 11, 12:51 PM",
    "curr_time": "01:14 AM",
    "bse_nse_vol": "1.18 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/concord-drugs-605306-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Concord Drugs Faces Significant Volatility Amidst Declining Stock Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-drugs-hits-new-52-week-low-amid-significant-stock-decline-and-volatility-1171178",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ConcordDrugs_priceRelatedfactors_561464.png",
        "date": "2025-03-03 09:36:26",
        "description": "Concord Drugs, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low today, reflecting significant volatility. The stock has dropped 21.73% over the past four days and is trading below all major moving averages, with a year-over-year decline of 29.29%."
      },
      {
        "title": "Concord Drugs Faces Significant Volatility Amidst Sustained Downward Trend in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-drugs-hits-52-week-low-of-rs-28-5-amid-ongoing-decline-959745",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/ConcordDrugs_priceRelatedfactors_409978.png",
        "date": "2025-02-11 14:35:21",
        "description": "Concord Drugs, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low today, reflecting significant volatility. The stock has fallen consecutively over three days, with notable intraday fluctuations. Its performance over the past year shows a decline, contrasting with broader market gains."
      },
      {
        "title": "Concord Drugs Faces Significant Stock Volatility Amid Industry Decline and Yearly Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-drugs-hits-52-week-low-of-rs-28-52-amid-ongoing-decline-2-351002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/1/ConcordDrugs_priceRelatedfactors_261545.png",
        "date": "2025-01-28 10:35:33",
        "description": "Concord Drugs, a microcap in the Pharmaceuticals & Drugs sector, faced significant volatility, hitting a new 52-week low. The stock has underperformed its sector and consistently traded below key moving averages. Over the past year, it has declined notably, contrasting with the overall market's gains."
      },
      {
        "title": "Concord Drugs Faces Significant Stock Volatility Amid Industry Decline and Yearly Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-drugs-hits-52-week-low-of-rs-28-52-amid-ongoing-decline-3-351036",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/1/ConcordDrugs_priceRelatedfactors_261545.png",
        "date": "2025-01-28 10:35:33",
        "description": "Concord Drugs, a microcap in the Pharmaceuticals & Drugs sector, faced significant volatility, hitting a new 52-week low. The stock has underperformed its sector and consistently traded below key moving averages. Over the past year, it has declined notably, contrasting with the overall market's gains."
      },
      {
        "title": "Concord Drugs Faces Significant Stock Volatility Amid Industry Decline and Yearly Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-drugs-hits-52-week-low-of-rs-28-52-amid-ongoing-decline-350995",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/1/ConcordDrugs_priceRelatedfactors_261545.png",
        "date": "2025-01-28 10:35:33",
        "description": "Concord Drugs, a microcap in the Pharmaceuticals & Drugs sector, faced significant volatility, hitting a new 52-week low. The stock has underperformed its sector and consistently traded below key moving averages. Over the past year, it has declined notably, contrasting with the overall market's gains."
      }
    ],
    "total": 21,
    "sid": "605306",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/concord-drugs-605306"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2025",
      "details": "Closure of Trading Window for the purpose of consideration of Audited Financial Results for quarter and year ending 31st March2025 from Tuesday April 1 2025 till 48 hours after declaration of financial results.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "17-Mar-2025",
      "details": "Outcome of Board Meeting",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Reschedule Of Board Meeting",
      "datetime": "13-Mar-2025",
      "details": "Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/03/2025 inter alia to consider and approve 1. Increase in Authorised Capital 2. Issue of shares on Preferential Allotment 3. Any other matter with the permission of chair",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Concord Drugs Faces Significant Volatility Amidst Declining Stock Performance

2025-03-03 09:36:26

Concord Drugs, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low today, reflecting significant volatility. The stock has dropped 21.73% over the past four days and is trading below all major moving averages, with a year-over-year decline of 29.29%.

Read More

Concord Drugs Faces Significant Volatility Amidst Sustained Downward Trend in Pharmaceuticals Sector

2025-02-11 14:35:21

Concord Drugs, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low today, reflecting significant volatility. The stock has fallen consecutively over three days, with notable intraday fluctuations. Its performance over the past year shows a decline, contrasting with broader market gains.

Read More

Concord Drugs Faces Significant Stock Volatility Amid Industry Decline and Yearly Underperformance

2025-01-28 10:35:33

Concord Drugs, a microcap in the Pharmaceuticals & Drugs sector, faced significant volatility, hitting a new 52-week low. The stock has underperformed its sector and consistently traded below key moving averages. Over the past year, it has declined notably, contrasting with the overall market's gains.

Read More

Concord Drugs Faces Significant Stock Volatility Amid Industry Decline and Yearly Underperformance

2025-01-28 10:35:33

Concord Drugs, a microcap in the Pharmaceuticals & Drugs sector, faced significant volatility, hitting a new 52-week low. The stock has underperformed its sector and consistently traded below key moving averages. Over the past year, it has declined notably, contrasting with the overall market's gains.

Read More

Concord Drugs Faces Significant Stock Volatility Amid Industry Decline and Yearly Underperformance

2025-01-28 10:35:33

Concord Drugs, a microcap in the Pharmaceuticals & Drugs sector, faced significant volatility, hitting a new 52-week low. The stock has underperformed its sector and consistently traded below key moving averages. Over the past year, it has declined notably, contrasting with the overall market's gains.

Read More

View All News